CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Shanghai Haohai Biological Tech Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Shanghai Haohai Biological Tech Co Ltd
4F, No 2 Building, Alley 139
Anshun Road, Changning District
Phone: +86 2152293555p:+86 2152293555 SHANGHAI, SHA  200336  China Ticker: 688366688366
Business Summary
Shanghai Haohai Biological Technology Co., Ltd. is a China-based company principally engaged in biological technology-related businesses. The businesses of the Company include the manufacture and sales of biological and medical hyaluronate, the research and development of biological engineering and pharmaceutical products and the provision of related services. Its products include orthopedics products, medical aesthetics and wound care products, ophthalmology products and anti-adhesion and hemostasis products, among others. Orthopedics products include sodium hyaluronate injection, medical chitosan and medical sodium hyaluronate gel. Medical aesthetics and wound care products include recombinant human epidermal growth factor (rhEGF), among others. Ophthalmology products include ophthalmic viscoelastic devices and lubricant eye drops. Anti-adhesion and hemostasis products include medical collagen sponges, among others. The Company mainly operates businesses in Mainland China.
(Source: F-4)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202412/31/2023Yes----

Industries
SIC Code Description
3842 Orthopedic, prosthetic, and surgical appliances and supplies
2833 Medicinal chemicals and botanical products
3851 Ophthalmic goods

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, Executive Director YongtaiHou 61 12/1/2014 12/1/2014
Finance Director, Executive Director MinjieTang 48 2/14/2017 12/1/2016
General Manager, Executive Director JianyingWu 53 12/1/2014 7/1/2010
10 additional Officers and Directors records available in full report.

Business Names
Business Name
6826
688366

General Information
Number of Employees: 2,158 (As of 12/31/2023)
Outstanding Shares: 234,190,295 (As of 10/30/2024)
Shareholders: 6,720
Stock Exchange: SHA
Fax Number: +86 2152293558


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, November 20, 2024